Identification of glycogene-based prognostic signature and validation of B3GNT7 as a potential biomarker and therapeutic target in breast cancer.
Wang X, Wang Y, Chen X, He Y, Zhou X, Jiao S, Zhu Z, Wu C, Bao J. J Cancer Res Clin Oncol. 2023 Dec; 149(19):16957-16969. Epub 2023 Sep 23.